ArticleCancers2023

Evaluating Focal Areas of Signal Intensity (FASI) in Children with Neurofibromatosis Type-1 (NF1) Treated with Selumetinib on Pediatric Brain Tumor Consortium (PBTC)-029B.

Natasha Pillay-Smiley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.